GB Sciences, Inc.
General ticker "GBLX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $489.4K (TTM average)
GB Sciences, Inc. does not follow the US Stock Market performance with the rate: -6.2%.
Estimated limits based on current volatility of 25.0%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 2 (-33.3%) as of 2024
- Top business risk factors: Limited operating history, Operational and conduct risks, Economic downturns and volatility, Market competition, Labor/talent shortage/retention
- Current price 91.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [0.00$, 0.01$]
- 2025-03-31 to 2026-03-31 estimated range: [0.00$, 0.01$]
Financial Metrics affecting the GBLX estimates:
- Positive: with PPE of -1.8 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -40.40 <= 0.33
- Negative: Shareholder equity ratio, % of -5135.32 <= 18.93
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 13.25 > -0.66
Short-term GBLX quotes
Long-term GBLX plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $1.87MM | $1.67MM | $1.42MM |
| Operating Income | $-1.87MM | $-1.67MM | $-1.42MM |
| Non-Operating Income | $1.72MM | $-2.45MM | $0.06MM |
| Interest Expense | $0.47MM | $0.18MM | $0.22MM |
| R&D Expense | $0.82MM | $0.00MM | $0.00MM |
| Income(Loss) | $-0.15MM | $-4.13MM | $-1.36MM |
| Profit(Loss)* | $-0.53MM | $-4.12MM | $-1.36MM |
| Stockholders Equity | $-1.78MM | $-4.41MM | $-5.31MM |
| Assets | $2.55MM | $0.35MM | $0.10MM |
| Operating Cash Flow | $-1.87MM | $-1.53MM | $-0.98MM |
| Capital expenditure | $0.20MM | $0.03MM | $0.00MM |
| Investing Cash Flow | $1.45MM | $-0.03MM | $0.32MM |
| Financing Cash Flow | $-0.50MM | $1.43MM | $0.56MM |
| Earnings Per Share** | $-0.00 | $-0.01 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.